p38 Mitogen-activated Protein Kinase Activates Peroxisome Proliferator-activated Receptor α
Open accessThe DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.
Abstract
The expression of enzymes involved in fatty acid beta-oxidation (FAO), the principal source of energy production in the adult mammalian heart, is controlled at the transcriptional level via the nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha). Evidence has emerged that PPARalpha activity is activated as a component of an energy metabolic stress response. The p38 mitogen-activated protein kinase (MAPK) pathway is activated by cellular stressors in the heart, including ischemia, hypoxia, and hypertrophic growth stimuli. We show here that PPARalpha is phosphorylated in response to stress stimuli in rat neonatal cardiac myocytes; in vitro kinase assays demonstrated that p38 MAPK phosphorylates serine residues located within the NH(2)-terminal A/B domain of the protein. Transient transfection studies in cardiac myocytes and in CV-1 cells utilizing homologous and heterologous PPARalpha target element reporters and mammalian one-hybrid transcription assays revealed that p38 MAPK phosphorylation of PPARalpha significantly enhanced ligand-dependent transactivation. Cotransfection studies performed with several known coactivators of PPARalpha demonstrated that p38 MAPK markedly increased coactivation specifically by PGC-1, a transcriptional coactivator implicated in myocyte energy metabolic gene regulation and mitochondrial biogenesis. These results identify PPARalpha as a downstream effector of p38 kinase-dependent stress-activated signaling in the heart, linking extracellular stressors to alterations in energy metabolic gene expression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Increasing evidence suggests that modifications can result in distinct effects on PGC-1α activity in a manner that is a) stimulus dependent and b) tissue dependent.”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [74]
In the citing paper
“the mitogen activated kinase p38 has been reported to increase PGC-1α activity upon stress in cardiac myocytes [74], in response to cytokines in myotubes [34] and is required for activation of PGC-1α through calcium calmodulin signaling pathway [75] or in response to trophic factors at the neuromuscular junction [76].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [74]
In the citing paper
“PPARα ligand dependent transcriptional activity and co-activation by PGC-1α is activated in heart by stress including ischemia, and hypoxia [74]”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [74]
Citations
Cites
Wu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R. C., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80611-x · Cited by 4,139
A simplified system for generating recombinant adenoviruses
He, T.-C., Zhou, S., da Costa, L. T., Yu, J., Kinzler, K. W., & Vogelstein, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2509 · Cited by 3,206
The p38 signal transduction pathway Activation and function
Ono, K., & Han, J. (2000) · Cellular Signalling · doi:10.1016/s0898-6568(99)00071-6 · Cited by 1,571
Peroxisome proliferator–activated receptor γ coactivator-1 promotes cardiac mitochondrial biogenesis
Lehman, J. J., Barger, P. M., Kovacs, A., Saffitz, J. E., Medeiros, D. M., & Kelly, D. P. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10268 · Cited by 1,285
Self-citationVega, R. B., Huss, J. M., & Kelly, D. P. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1868-1876.2000 · Cited by 1,195
Self-citationInhibition of Adipogenesis Through MAP Kinase-Mediated Phosphorylation of PPARγ
Hu, E., Kim, J. B., Sarraf, P., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.274.5295.2100 · Cited by 1,050
Leone, T. C., Weinheimer, C. J., & Kelly, D. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7473 · Cited by 943
Self-citationWang, Y., Huang, S., Sah, V. P., Ross, J., Brown, J. H., Han, J., & Chien, K. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.4.2161 · Cited by 842
Fatty Acid Oxidation Enzyme Gene Expression Is Downregulated in the Failing Heart
Sack, M. N., Rader, T. A., Park, S., Bastin, J., McCune, S. A., & Kelly, D. P. (1996) · Circulation · doi:10.1161/01.cir.94.11.2837 · Cited by 677
Self-citationGulick, T., Cresci, S., Caira, T., Moore, D. D., & Kelly, D. P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.11012 · Cited by 560
Self-citation
Research works printed but not linked: 2
- Horowitz, 2000, Am. J. Physiol., 279, E348
- Baes, 1994, Mol. Cell. Biol., 14, 1544
Cited by
Cloning of adiponectin receptors that mediate antidiabetic metabolic effects
Yamauchi, T., Kamon, J., Ito, Y., Tsuchida, A., Yokomizo, T., Kita, S., Sugiyama, T., Miyagishi, M., Hara, K., Tsunoda, M., et al. (2003) · Nature · doi:10.1038/nature01705 · Cited by 3,176
Puigserver, P., & Spiegelman, B. M. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0012 · Cited by 2,076
Pawlak, M., Lefebvre, P., & Staels, B. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.10.039 · Cited by 1,578
“The A/B domain contains the AF-1 region providing basal, ligand-binding-independent and -dependent activity, which can be potentiated by MAPK phosphorylation of serines 6, 12, and 21 [11].”
BackgroundTranscriptional regulatory circuits controlling mitochondrial biogenesis and function
Kelly, D. P., & Scarpulla, R. C. (2004) · Genes & Development · doi:10.1101/gad.1177604 · Cited by 1,243
Self-citationThe MAPK cascades: Signaling components, nuclear roles and mechanisms of nuclear translocation
Plotnikov, A., Zehorai, E., Procaccia, S., & Seger, R. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.12.012 · Cited by 986
“For example, it was shown that PPARα is phosphorylated by p38s upon ischemia, hypoxia, and other stresses of cardiac myocytes [171,172].”
BackgroundSorting out the roles of PPAR in energy metabolism and vascular homeostasis
Lefebvre, P. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27989 · Cited by 962
Molecular Actions of PPARα in Lipid Metabolism and Inflammation
Bougarne, N., Weyers, B., Desmet, S. J., Deckers, J., Ray, D. W., Staels, B., & De Bosscher, K. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00064 · Cited by 898
Transcriptional Regulation of Metabolism
Desvergne, B., Michalik, L., & Wahli, W. (2006) · Physiological Reviews · doi:10.1152/physrev.00025.2005 · Cited by 892
Feige, J. N., Gelman, L., Michalik, L., Desvergne, B., & Wahli, W. (2006) · Progress in Lipid Research · doi:10.1016/j.plipres.2005.12.002 · Cited by 786
Luen Tang, B. (2016) · Molecules and Cells · doi:10.14348/molcells.2016.2318 · Cited by 740
“PGC-1α is phosphorylated by both Mitogen-activated protein kinase p38 (Barger et al., 2001), and the AMP-dependent kinase (AMPK) in skeletal muscle (Leick et al., 2010), which also stabilizes the protein and increases its activity.”
BackgroundAkimoto, T., Pohnert, S. C., Li, P., Zhang, M., Gumbs, C., Rosenberg, P. B., Williams, R. S., & Yan, Z. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m408862200 · Cited by 714
Yoon, M. J., Lee, G. Y., Chung, J.-J., Ahn, Y. H., Hong, S. H., & Kim, J. B. (2006) · Diabetes · doi:10.2337/db05-1322 · Cited by 546
“Of note, p38 MAPK is known to phosphorylate PPAR and increase its association with a coactivator PPAR coativator-1 (36).”
BackgroundMitochondrial energy metabolism in heart failure: a question of balance
Huss, J. M., & Kelly, D. P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524405 · Cited by 533
Self-citationNumber matters: control of mammalian mitochondrial DNA copy number
Clay Montier, L. L., Deng, J. J., & Bai, Y. (2009) · Journal of Genetics and Genomics · doi:10.1016/s1673-8527(08)60099-5 · Cited by 512
“…fatty acid oxidation and can cause massive mitochondrial proliferation in cardiac cells (Lehman, 2000). p38MAPK can activate PGC-1 (Knutti and Kralli, 2001) and its partner PPAR (Barger et al., 2001), suggesting that it has a role in mitochondrial biogenesis (Kelly and Scarpulla, 2004).”
BackgroundInfluentialTranscriptional regulation by the MAP kinase signaling cascades
Yang, S.-H., Sharrocks, A. D., & Whitmarsh, A. J. (2003) · Gene · doi:10.1016/s0378-1119(03)00816-3 · Cited by 494
Huss, J. M., Torra, I. P., Staels, B., Giguère, V., & Kelly, D. P. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.20.9079-9091.2004 · Cited by 485
Self-citationHuss, J. M., Kopp, R. P., & Kelly, D. P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206324200 · Cited by 479
Self-citationModulation of PPAR activity via phosphorylation
BURNS, K., & VANDENHEUVEL, J. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.04.018 · Cited by 443
Self-regulation of the inflammatory response by peroxisome proliferator-activated receptors
Korbecki, J., Bobiński, R., & Dutka, M. (2019) · Inflammation Research · doi:10.1007/s00011-019-01231-1 · Cited by 415
Muoio, D. M., MacLean, P. S., Lang, D. B., Li, S., Houmard, J. A., Way, J. M., Winegar, D. A., Corton, J. C., Dohm, G. L., & Kraus, W. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203997200 · Cited by 398
PPARα: Energy Combustion, Hypolipidemia, Inflammation and Cancer
Pyper, S. R., Viswakarma, N., Yu, S., & Reddy, J. K. (2010) · Nuclear Receptor Signaling · doi:10.1621/nrs.08002 · Cited by 379
Mitochondria as a Therapeutic Target in Heart Failure
Bayeva, M., Gheorghiade, M., & Ardehali, H. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.08.1021 · Cited by 332
Molecular Mechanisms of Alcoholic Fatty Liver
Purohit, V., Gao, B., & Song, B. (2009) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00827.x · Cited by 312
Blanquart, C., Barbier, O., Fruchart, J. C., Staels, B., & Glineur, C. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00214-0 · Cited by 312
Zayzafoon, M., Gathings, W. E., & McDonald, J. M. (2004) · Endocrinology · doi:10.1210/en.2003-1156 · Cited by 297
After the banquet: Mitochondrial biogenesis, mitophagy, and cell survival
Zhu, J., Wang, K. Z., & Chu, C. T. (2013) · Autophagy · doi:10.4161/auto.24135 · Cited by 293
Nuclear receptors: integration of multiple signalling pathways through phosphorylation
Rochette-Egly, C. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(02)00115-8 · Cited by 291
APPL1: role in adiponectin signaling and beyond
Deepa, S. S., & Dong, L. Q. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90731.2008 · Cited by 287
Metabolic remodelling of the failing heart: the cardiac burn-out syndrome?
VANBILSEN, M., SMEETS, P., GILDE, A., & VANDERVUSSE, G. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.11.014 · Cited by 261
Remodeling of White Adipose Tissue after Retinoic Acid Administration in Mice
Mercader, J., Ribot, J., Murano, I., Felipe, F., Cinti, S., Bonet, M. L., & Palou, A. (2006) · Endocrinology · doi:10.1210/en.2006-0760 · Cited by 251
Cytokine Signaling Modulates Blood-Brain Barrier Function
Pan, W., P. Stone, K., Hsuchou, H., K. Manda, V., Zhang, Y., & J. Kastin, A. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211798220918 · Cited by 241
The Biological Actions of Dehydroepiandrosterone Involves Multiple Receptors
Webb, S. J., Geoghegan, T. E., Prough, R. A., & Michael Miller, K. K. (2006) · Drug Metabolism Reviews · doi:10.1080/03602530600569877 · Cited by 237
“Further, Barger et al. (2001) demonstrated that PPARα phosphorylation in primary rat neonatal cardiomyocytes stimulated its transcriptional activity, while in an earlier report the same authors using the same cells, showed in that PPARα phosphorylation by ERKMAPK decreased PPARα activity.”
Resultp38 Pathway Kinases as Anti-inflammatory Drug Targets
Schindler, J. F., Monahan, J. B., & Smith, W. G. (2007) · Journal of Dental Research · doi:10.1177/154405910708600902 · Cited by 227
“…kinases, and other enzymes. p38 MAPK can directly phosphorylate several transcription factors, such as myocyte-specific enhancer binding factor 2C (MEF2C), CHOP, PPAR co-activator 1, peroxisome proliferator-activated receptor , and p53 (Wang and Ron, 1996; Han et al., 1997; Barger et al., 2001).”
BackgroundYou, M., & Crabb, D. W. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00056.2004 · Cited by 225
The PPAR regulatory system in cardiac physiology and disease
FINCK, B. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.08.023 · Cited by 223
Transcription coactivators for peroxisome proliferator-activated receptors
YU, S., & REDDY, J. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.01.008 · Cited by 222
Be Fit or Be Sick: Peroxisome Proliferator-Activated Receptors Are Down the Road
Desvergne, B., Michalik, L., & Wahli, W. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0088 · Cited by 222
“In parallel, the expression of the PPAR coactivator-1 (PGC-1), which has an important role in mitochondrial biogenesis and thus in the cellular oxidative capacity (19), is stimulated and may cooperate with PPAR for the induction of the fatty acid oxidation pathway (20).”
BackgroundFunctional Regulation of PPARs through Post-Translational Modifications
Brunmeir, R., & Xu, F. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061738 · Cited by 219
“Specific serine residues in PPARα have emerged as important phosphorylation sites: serine 12 and 21, which are both targeted by either Mitogen-activated protein kinases (MAPKs) [12,13] or Cyclin-dependent kinase (CDK) 7 [14].”
BackgroundLipid metabolism in mammalian tissues and its control by retinoic acid
Bonet, M. L., Ribot, J., & Palou, A. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.06.001 · Cited by 215
PGC-1α and ERRα target gene downregulation is a signature of the failing human heart
Sihag, S., Cresci, S., Li, A. Y., Sucharov, C. C., & Lehman, J. J. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.10.025 · Cited by 214
Wu, J. J., Roth, R. J., Anderson, E. J., Hong, E.-G., Lee, M.-K., Choi, C. S., Neufer, P. D., Shulman, G. I., Kim, J. K., & Bennett, A. M. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.05.010 · Cited by 212
“PGC-1a which stimulates the transcription of a number of mitochondrial genes involved in energy expenditure, is a direct target for activation by p38 MAPK (Puigserver et al., 2001).”
BackgroundMethodInfluentialTsuda, T., Ueno, Y., Aoki, H., Koda, T., Horio, F., Takahashi, N., Kawada, T., & Osawa, T. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.02.031 · Cited by 212
PPARs and the Cardiovascular System
Hamblin, M., Chang, L., Fan, Y., Zhang, J., & Chen, Y. E. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2280 · Cited by 207
Isoflavones Promote Mitochondrial Biogenesis
Rasbach, K. A., & Schnellmann, R. G. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.134882 · Cited by 206
“The transcriptional activity of PGC-1 can be increased by posttranslational modifications, including p38 MAPK-dependent phosphorylation of PGC-1 to promote the dissociation of the negative regulator p160 myb-binding protein (Knutti et al., 2001; Fan et al., 2004) and subsequent nuclear localization (Puigserver et al.,…”
BackgroundInfluentialAngiopoietin-related growth factor antagonizes obesity and insulin resistance
Oike, Y., Akao, M., Yasunaga, K., Yamauchi, T., Morisada, T., Ito, Y., Urano, T., Kimura, Y., Kubota, Y., Maekawa, H., et al. (2005) · Nature Medicine · doi:10.1038/nm1214 · Cited by 200
“Oxygen consumption (VO 2 ) was determined in 6-month-old Angptl6 −/− mice and controls ( n = 5 each), and 5-month-old Angptl6 -transgenic mice and controls ( n = 12 each), with an O 2 /CO 2 metabolic measuring system (Model MK-5000, Muromachikikai) at 24 °C as described elsewher”
MethodMcClelland, G. B., Craig, P. M., Dhekney, K., & Dipardo, S. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.119032 · Cited by 190
“It is important to note that many transcription factors can be regulated by kinase pathways such as the p38-MAPK and ERK-MAPK pathways, at least in mammals (e.g. Barger et al. 2000, 2001).”
BackgroundPPARs: Regulators of Metabolism and As Therapeutic Targets in Cardiovascular disease. Part I: PPAR-α
Han, L., Shen, W.-J., Bittner, S., Kraemer, F. B., & Azhar, S. (2017) · Future Cardiology · doi:10.2217/fca-2016-0059 · Cited by 183
Gilde, A. J., & Van Bilsen, M. (2003) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.2003.01161.x · Cited by 178
Phosphorylation of PPARs: from molecular characterization to physiological relevance
Diradourian, C., Girard, J., & Pégorier, J.-P. (2005) · Biochimie · doi:10.1016/j.biochi.2004.11.010 · Cited by 178
Chen, L., Qin, Y., Liu, B., Gao, M., Li, A., Li, X., & Gong, G. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.871357 · Cited by 171
Todisco, S., Santarsiero, A., Convertini, P., Stefano, G. D., Gilio, M., Iacobazzi, V., & Infantino, V. (2022) · Biology · doi:10.3390/biology11050792 · Cited by 181
Sethi, S., Ziouzenkova, O., Ni, H., Wagner, D. D., Plutzky, J., & Mayadas, T. N. (2002) · Blood · doi:10.1182/blood-2002-01-0316 · Cited by 166
Paumelle, R., Blanquart, C., Briand, O., Barbier, O., Duhem, C., Woerly, G., Percevault, F., Fruchart, J.-C., Dombrowicz, D., Glineur, C., et al. (2006) · Circulation Research · doi:10.1161/01.res.0000202706.70992.95 · Cited by 165
Han, J., Wu, J., & Silke, J. (2020) · F1000Research · doi:10.12688/f1000research.22092.1 · Cited by 174
PGC-1α in aging and anti-aging interventions
Anderson, R., & Prolla, T. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.04.005 · Cited by 162
Chaube, B., Malvi, P., Singh, S. V., Mohammad, N., Viollet, B., & Bhat, M. K. (2015) · Cell Death Discovery · doi:10.1038/cddiscovery.2015.63 · Cited by 162
Nasoohi, S., Ismael, S., & Ishrat, T. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0917-z · Cited by 160
Sex-specific pathways in early cardiac response to pressure overload in mice
Witt, H., Schubert, C., Jaekel, J., Fliegner, D., Penkalla, A., Tiemann, K., Stypmann, J., Roepcke, S., Brokat, S., Mahmoodzadeh, S., et al. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0385-4 · Cited by 159
“PGC-1 stimulates mitochondrial biogenesis and fatty acid oxidation and reduces glucose oxidation in the myocardium [36, 37].”
Mitogen-Activated Protein Kinase Regulation in Hepatic Metabolism
Lawan, A., & Bennett, A. M. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2017.10.007 · Cited by 159
Holdsworth‐Carson, S. J., Lim, R., Mitton, A., Whitehead, C. L., Rice, G. E., Permezel, M., & Lappas, M. (2010) · Placenta · doi:10.1016/j.placenta.2009.12.009 · Cited by 169
Oxidative Stress and Transcriptional Regulation in Alzheimer Disease
Shi, Q., & Gibson, G. E. (2007) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31815721c3 · Cited by 157
“p38MAPK activates PGC-1a(207,208) and PPARa.(209) It is a great challenge to understand the integration of these signalling pathways involved in mitochondrial function and biogenesis in response to oxidative stress.”
BackgroundFunk, J. A., Odejinmi, S. I., & Schnellmann, R. G. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.161992 · Cited by 161
“…Wrutniak-Cabello et al., 2001); signaling pathways, such as the mitogen-activated protein kinase and Ca2 /calmodulin-dependent kinase pathways (Barger et al., 2001; Wu et al., 2002); and posttranslational phosphorylation, methylation, and acetylation modifications (Barger et al., 2001;…”
BackgroundWan, Z., Root‐Mccaig, J., Castellani, L., Kemp, B. E., Steinberg, G. R., & Wright, D. C. (2014) · Obesity · doi:10.1002/oby.20605 · Cited by 146
Ichida, M., Nemoto, S., & Finkel, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m210262200 · Cited by 138
Hellemans, K., Michalik, L., Dittie, A., Knorr, A., Rombouts, K., de Jong, J., Heirman, C., Quartier, E., Schuit, F., Wahli, W., et al. (2003) · Gastroenterology · doi:10.1053/gast.2003.50015 · Cited by 137
Control of mitochondrial biogenesis during myogenesis
Kraft, C. S., LeMoine, C. M. R., Lyons, C. N., Michaud, D., Mueller, C. R., & Moyes, C. D. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00463.2005 · Cited by 131
“6 and 7). The myogenic increase in COX was curtailed by SB-203580, an inhibitor of p38-MAPK, the known targets of which include PPAR ( 5 ) and PGC1 (22).”
BackgroundPeroxisome-proliferator-activated receptors regulate redox signaling in the cardiovascular system
Kim, T., & Yang, Q. (2013) · World Journal of Cardiology · doi:10.4330/wjc.v5.i6.164 · Cited by 139
Robinson, E., & Grieve, D. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.03.003 · Cited by 138
Activated AMPK inhibits PPAR-α and PPAR-γ transcriptional activity in hepatoma cells
Sozio, M. S., Lu, C., Zeng, Y., Liangpunsakul, S., & Crabb, D. W. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00432.2010 · Cited by 127
Petrich, B. G., & Wang, Y. (2004) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2003.11.002 · Cited by 142
PPARα Is Regulated by miR-21 and miR-27b in Human Liver
Kida, K., Nakajima, M., Mohri, T., Oda, Y., Takagi, S., Fukami, T., & Yokoi, T. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0473-y · Cited by 130
Wang, X., Wu, H., & Miller, A. H. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001339 · Cited by 128
“50 as well as other nuclear receptors such as peroxisome proliferator-activated receptor α”
BackgroundNovel Small-Molecule PGC-1α Transcriptional Regulator With Beneficial Effects on Diabetic db/db Mice
Zhang, L., Zhou, H., Fu, Y., Li, Y., Wu, F., Gu, M., Wu, L., Xia, C.-M., Dong, T., Li, J.-Y., et al. (2013) · Diabetes · doi:10.2337/db12-0703 · Cited by 132
Fat to the fire: the regulation of lipid oxidation with exercise and environmental stress
McClelland, G. B. (2004) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpc.2004.07.003 · Cited by 147
“Conversely, p38-MAPK activation has been found to increase PPAR activity (Barger et al., 2001).”
BackgroundMuzio, G., Barrera, G., & Pizzimenti, S. (2021) · Antioxidants · doi:10.3390/antiox10111734 · Cited by 128
Mimetics of Caloric Restriction Include Agonists of Lipid-activated Nuclear Receptors
Corton, J. C., Apte, U., Anderson, S. P., Limaye, P., Yoon, L., Latendresse, J., Dunn, C., Everitt, J. I., Voss, K. A., Swanson, C., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406739200 · Cited by 113
Zhang, X., Du, L., Zhang, W., Yang, Y., Zhou, Q., & Du, G. (2017) · Scientific Reports · doi:10.1038/s41598-017-07442-y · Cited by 110
Sun, K., Montana, V., Chellappa, K., Brelivet, Y., Moras, D., Maeda, Y., Parpura, V., Paschal, B. M., & Sladek, F. M. (2007) · Molecular Endocrinology · doi:10.1210/me.2006-0300 · Cited by 99
Blanquart, C., Mansouri, R., Paumelle, R., Fruchart, J.-C., Staels, B., & Glineur, C. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0327 · Cited by 101
Corton, J. C., & Brown-Borg, H. M. (2005) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/60.12.1494 · Cited by 106
Gardner, O., Dewar, B. J., Earp, H. S., Samet, J. M., & Graves, L. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307827200 · Cited by 117
Okere, I. C., Young, M. E., McElfresh, T. A., Chess, D. J., Sharov, V. G., Sabbah, H. N., Hoit, B. D., Ernsberger, P., Chandler, M. P., & Stanley, W. C. (2006) · Hypertension · doi:10.1161/01.hyp.0000248430.26229.0f · Cited by 104
Akimoto, M., Maruyama, R., Kawabata, Y., Tajima, Y., & Takenaga, K. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0851-z · Cited by 104
Teruel, T., Hernandez, R., Benito, M., & Lorenzo, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207200200 · Cited by 96
p38 MAPK in Glucose Metabolism of Skeletal Muscle: Beneficial or Harmful?
Bengal, E., Aviram, S., & Hayek, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186480 · Cited by 114
Transcriptional control of mitochondrial biogenesis and its interface with inflammatory processes
Piantadosi, C. A., & Suliman, H. B. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.01.003 · Cited by 98
“In the heart, p38 activates the nuclear peroxisome proliferatoractivated receptor alpha (PPARα) through its PGC-1α co-activator [51].”
BackgroundMechanisms and metabolic regulation of PPARα activation in Nile tilapia (Oreochromis niloticus)
Ning, L.-J., He, A.-Y., Li, J., Lu, D., Jiao, J., Li, L., Li, D., Zhang, M., Chen, L., & Du, Z. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.06.005 · Cited by 104
Gardner, O., Dewar, B. J., & Graves, L. M. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.012260 · Cited by 110
“In particular, ERK- and p38-dependent PPAR phosphorylation resulted in increased transcriptional activity (Juge-Aubry et al., 1999; Barger et al., 2001), whereas PPAR phosphorylation by MAPKs decreased transcriptional activity (Hu et al.”
BackgroundLee, W.-S., & Kim, J. (2015) · PPAR Research · doi:10.1155/2015/271983 · Cited by 91
Nandakumar, M., & Tan, M. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000273 · Cited by 108
“. Conversely, the p38 MAP kinase pathway has also been implicated in the control of PPARα activation and function. In vitro analysis shows that phosphorylation by p38 MAP kinase enhances activity of PPARα in cardiomyocytes”
BackgroundHinds, T. D., Hosick, P. A., Chen, S., Tukey, R. H., Hankins, M. W., Nestor-Kalinoski, A., & Stec, D. E. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00396.2016 · Cited by 90
Rupp, H., Zarain‐Herzberg, Á., & Maisch, B. (2002) · Herz · doi:10.1007/s00059-002-2428-x · Cited by 99
“tivated signaling in cardiomyocytes [7].”
Wadosky, K. M., & Willis, M. S. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00703.2011 · Cited by 90
Hepatic PPARs: Their Role in Liver Physiology, Fibrosis and Treatment
Zardi, E., Navarini, L., Sambataro, G., Piccinni, P., Sambataro, F., Spina, C., & Dobrina, A. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990136 · Cited by 90
Origins and Consequences of Mitochondrial Variation in Vertebrate Muscle
Moyes, C. D., & Hood, D. A. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142705 · Cited by 101
All-Trans Retinoic Acid Increases Oxidative Metabolism in Mature Adipocytes
Mercader, J., Madsen, L., Felipe, F., Palou, A., Kristiansen, K., & Bonet, L. (2007) · Cellular Physiology and Biochemistry · doi:10.1159/000110717 · Cited by 83
Boitier, E., Gautier, J.-C., & Roberts, R. (2003) · Comparative Hepatology · doi:10.1186/1476-5926-2-3 · Cited by 85
Diversity and specificity of the mitogen-activated protein kinase phosphatase-1 functions
Lawan, A., Shi, H., Gatzke, F., & Bennett, A. M. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1041-2 · Cited by 81
“The MAPKs have previously been implicated in the regulation of metabolic homeostasis mainly through targeting the phosphorylation of transcription factors that control processes such as adipogenesis, insulin signaling, glucose uptake, fatty acid metabolism, lipogenesis, and energy expenditure [74–81].”
BackgroundMahmoudvand, S., Shokri, S., Taherkhani, R., & Farshadpour, F. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i1.42 · Cited by 89
Arany, Z., Wagner, B. K., Ma, Y., Chinsomboon, J., Laznik, D., & Spiegelman, B. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800979105 · Cited by 82
Metadata
- Authors
- Barger, P. M., Browning, A. C., Garner, A. N., & Kelly, D. P.
- Affiliations
- Washington University in St. Louis (US)
- Corresponding author
- Kelly, Daniel P.
- ORCID
- Kelly, Daniel P.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-11
- Volume
- 276
- Issue
- 48
- Pages
- 44495-44501
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1975717275
- Cited by
- 260
- References
- 47
- Citations by year
- 2025: 9 · 2024: 4 · 2023: 5 · 2022: 7 · 2021: 6 · 2020: 11 · 2019: 6 · 2018: 12 · 2017: 11 · 2016: 3 · 2015: 9 · 2014: 5 · 2013: 10 · 2012: 13
- FWCI
- 5.60
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6922 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5k08hl003808-02, 5p50hl061006-05)
- National Heart, Lung, and Blood Institute (R01-HL-58493, K08 HL03808, P50-HL-61006, R01HL058493)
- National Institute of Diabetes and Digestive and Kidney Diseases (P01 DK52574, P30-DK56341, P30DK056341)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- p38 MAPK, PPARα, protein phosphorylation, cardiomyocytes, fatty acid beta-oxidation, energy metabolism, PGC-1, transcriptional coactivation, ligand-dependent transactivation, stress-activated signaling, myocardial energy metabolism, mitochondrial biogenesis
- MeSH terms
- Adenoviridae, Amino Acid Sequence, Animals, Animals, Newborn, Binding Sites, Cell Line, Cells, Cultured, Chlorocebus aethiops, Enzyme Activation, Imidazoles, Molecular Sequence Data, Myocardium, Phosphates, Phosphorylation, Protein Binding, Pyridines, Serine, Time Factors, Transcription Factors, Transcription, Genetic, Transfection, Signal Transduction, Transcriptional Activation, Protein Structure, Tertiary, Receptors, Cytoplasmic and Nuclear, Dimerization, Oleic Acid, Two-Hybrid System Techniques, Mitogen-Activated Protein Kinases, MAP Kinase Signaling System, p38 Mitogen-Activated Protein Kinases, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.